author-photo

Indrajeet Singh

Janssen Pharmaceutica

9

Papers

263

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study

2021 The Lancet
Show All
- Source
- Cite
- Save
Citations (28)
Update of CARTITUDE-1: A phase Ib/II study of JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell therapy, in relapsed/refractory multiple myeloma.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (58)
Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 study.

2020 Leukemia
Show All
- Source
- Cite
- Save
Citations (24)
Results from CARTITUDE-1: A Phase 1b/2 Study of JNJ-4528, a CAR-T Cell Therapy Directed Against B-Cell Maturation Antigen (BCMA), in Patients with Relapsed and/or Refractory Multiple Myeloma (R/R MM)

2019 Blood
Show All
- Source
- Cite
- Save
Citations (69)
Development of a CD123xCD3 Bispecific Antibody (JNJ-63709178) for the Treatment of Acute Myeloid Leukemia (AML)

2016 Blood
Show All
- Source
- Cite
- Save
Citations (22)
Abstract 2085: Development of a mechanism-based pharmacokinetic/pharmacodynamic model to characterize tumor killing effect of an anti-VISTA monoclonal antibody in tumor bearing mice

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)